Ee. Soffer et al., MORPHOLOGY AND PATHOLOGY OF RADIATION-INDUCED ESOPHAGITIS - DOUBLE-BLIND-STUDY OF NAPROXEN VS PLACEBO FOR PREVENTION OF RADIATION-INJURY, Digestive diseases and sciences, 39(3), 1994, pp. 655-660
Radiation-induced esophagitis can cause substantial morbidity. Experim
ents in lab animals have shown that pretreatment with indomethacin pro
tects the esophagus from radiation damage. We conducted a prospective,
double-blind, randomized trial of naproxen vs placebo in patients und
ergoing thoracic radiation therapy for lung cancer. Twenty-eight patie
nts were enrolled, of which 26 completed the study. Sixteen patients w
ere given a short course of radiation (30 Gy/10 fractions/2 weeks), an
d 10 patients were given a longer course and a larger dose (40-50 Gy/2
5 fractions/5 weeks). Half of the irradiated patients were treated wit
h naproxen, 375 mg, taken orally twice a day, and half were given an i
dentical placebo. All patients were given ranitidine 300 mg, taken ora
lly once a day Study drugs were taken throughout the course of radiati
on. Endoscopy with esophageal biopsies and brushings was performed bef
ore and on the last day of treatment. Patients kept a daily diary for
symptom scoring. Symptoms such as chest pain, dysphagia, odynophagia,
and/or heartburn were reported in 15 patients from both subgroups, res
ulting in diet restriction to liquids only in eight patients and requi
ring temporary discontinuation of radiation therapy in one of them App
roximately half the patients in each subgroup developed esophagitis, u
sually mild and usually limited to the proximal esophagus. Seventy of
symptoms was not proportional to the severity of esophagitis. Candidia
sis was documented in eight patients, but only four had symptoms that
were severe in one. We conclude that acute radiation injury to the eso
phagus is observed in approximately half the patients receiving radiat
ion therapy and can result in substantial morbidity. Treatment with a
prostaglandin inhibitor, naproxen, was not protective. Esophagitis may
be complicated by esophageal candidiasis, but its contribution to the
patient's morbidity is unclear.